New NIAID grants for biotech HIV programs

The National Institute of Allergy and Infectious Diseases launched a new initiative, the Strategic Program for Innovative Research on AIDS Treatment (SPIRAT), to accelerate the development of therapies for HIV. First-year grants totalling $6.2 million will support six research teams, each coupling companies with investigators from separate U.S. institutions. The teams will receive funding for four years, with early human studies to commence, at the latest, by the third year of the awards.

Targeted Genetics Corp. (TGEN) and the